The New Silicone N99 Half-Piece Respirator
NCT04454606 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 43
Last updated 2020-07-01
Summary
Filter facepiece respirator (FFR) is a critical equipment to prevent the transmission of respiratory tract infection disease especially the dreadful corona virus 2(SARs-CoV-2).The N95 mask is the prototype of high efficiency protective device and can effectively protect airborne pathogens of less than 0.3 μm by more than 95%. It is tightly fit and had high filtration capacity. The widespread pandemic of COVID-19 leads to greater requirement of FFR. A rising in demand would greatly exceed current productive capabilities and stockpiles and would almost certainly result in a robust shortage.
In order to solve these problems, our team had invented a new type of half-piece respirator made from silicone and assembled with hepa or elastostatic filter . A variety of methods have been used to evaluate this new device, including qualitative fit test with Bitrex® test kit and filtration test.
Conditions
- COVID
- Personal Protective Equipment
Interventions
- DEVICE
-
Fit test
Bitrex Fit Test The Bitrex test uses a person's ability to test a bitter solution to determine whether a respirator fits properly\[11\]. Each subject was given a taste-threshold screening test prior to each fit test to ensure that he or she could taste. This process was done without subject wearing a respirator. After passing the sensitivity test, the subject will process to 7 steps of fit test as following * Breathe normally * Breathe deeply * Head side to side * Head up and down * Bent over wrist, jogging * Talking * Breath normally Each step took 60 seconds and the Bitrex solution was refilled into the hood every 30 seconds with half dosage of the amount of the previously test. We asked the participant if he / she could taste the solution during each steps of the test . The test was considered a failure, otherwise, a pass.
- DEVICE
-
Filtration Test
Respirator Performance The real time respirator performance test method was developed using MT-05U machine (SIBATA model, Saitama, Japan), which measure particle concentrations of diameter 0.03 - 0.06 µm using and particle generator laser beam scattering particle counter that measure particles outside and inside the mask. The ratio between these two values reflected % leak as following: * leak=((Paticle inside the filter))/((Paticle inside the filter)) x 100 And calculate % filter performance = 100 - % leak We tested at the airflow rate of 40L/min which is 3-4 times higher than normal physiology, assuming that there should be no leakage through the filter. We tested 2 types of filter is CareStar and SafeStar that was incorporated with the silicone mask. CareStar is limited for 24 hour usage and SafeStar is for 72 hour duration. Study protocol
Sponsors & Collaborators
-
Bangkok Metropolitan Administration Medical College and Vajira Hospital
lead OTHER_GOV
Principal Investigators
-
Thananda Trakarnvanich, M.D. · Bangkok Metropolitan Administration and Vajira Hospital
Study Design
- Allocation
- NA
- Purpose
- PREVENTION
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Max Age
- 60 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2020-05-01
- Primary Completion
- 2020-05-15
- Completion
- 2020-05-31
Countries
- Thailand
Study Locations
More Related Trials
-
Convalescent Plasma as Treatment for Subjects With Early COVID-19 Infection
NCT04456413 ·Status: TERMINATED ·Phase: PHASE2
-
Philips FAST Evaluation
NCT06860230 ·Status: COMPLETED
-
Convalescent Plasma Collection and Treatment in Pediatrics and Adults
NCT04376034 ·Status: RECRUITING ·Phase: PHASE3
-
Device to Reduce Surgery Site Contamination
NCT00972153 ·Status: COMPLETED ·Phase: NA
-
Evaluation of Rapid Diagnostic Solutions, Serological and Molecular Tests for COVID-19
NCT04405492 ·Status: UNKNOWN ·Phase: NA
-
ANTIBODY BASED TESTS FOR SARSCoV-2 COVID-19) - Evaluation of Patients and Healthcare Providers in the Confines of Healthcare Settings
NCT04352764 ·Status: UNKNOWN
-
The Nanowear Wearable Covid-19 Observational and Analysis Trend
NCT04717024 ·Status: TERMINATED
-
A Study Comparing Time to Intubate With and Without a Barrier Box
NCT04411056 ·Status: COMPLETED ·Phase: NA
-
Hexoskin Feasibility Study With COVID-19 Patients
NCT04453891 ·Status: WITHDRAWN
-
COVID-19: A POC Test Under Research & Evaluation
NCT04408066 ·Status: SUSPENDED ·Phase: NA
-
Extracorporeal Blood Purification as a Treatment Modality for COVID-19
NCT04478539 ·Status: COMPLETED
-
Clinical Investigational Protocol for 2 RBC Single Unit Recovery on MCS®+ 8150 Using LN832 Disposable Sets (US)
NCT01764061 ·Status: COMPLETED
-
Evaluation of the Safety and Efficacy of Single-use Precision Filtered Infusion Sets for Intravenous Infusion
NCT04962516 ·Status: COMPLETED
-
Clinical Investigation to Evaluate the Haemonetics POLFA Modified Sample Needle Assembly With Vacuum Tube Holder
NCT02476851 ·Status: COMPLETED ·Phase: NA
-
Human Research Program Flight Thigh Cuff
NCT06476106 ·Status: ENROLLING_BY_INVITATION ·Phase: NA
-
Wearable Diagnostic for Detection of COVID-19 Infection
NCT04742569 ·Status: COMPLETED
-
Safety and Performance of Short- and Long-term Baseplates for Attaching the UNEEG Episight Recorder - Part I
NCT05111847 ·Status: COMPLETED ·Phase: NA
-
Study for Testing and Reviewing Improvised PPE Effectiveness 3 (STRIPE-3)
NCT04362163 ·Status: COMPLETED
-
Exploration of Feasability of Blood and Saliva Proteomic Analysis Through Harvesting by Silica Matrix (NanoDx-CoV-19)
NCT04597216 ·Status: UNKNOWN ·Phase: NA
-
Convalescent Plasma for COVID-19 Research Donor Study
NCT04555109 ·Status: UNKNOWN
-
Investigational Performance Evaluation of the Nanomix eLab® COVID-19 Rapid Antigen Panel With Samples From COVID-19 Positive and Negative Human Subjects
NCT04667442 ·Status: COMPLETED
-
Evaluation of the Clinical Performance of the ZIKV Detect™ 2.0 IgM Capture ELISA
NCT03776903 ·Status: COMPLETED
-
A Study To Evaluate The Performance of the Lucira Health All-In-One COVID-19 Test Kit vs Hologic Panther Fusion
NCT04720794 ·Status: COMPLETED ·Phase: NA
-
COVID Card Pilot Study to Detect Antibodies to SARS-CoV-2
NCT05196932 ·Status: COMPLETED
-
Passive Detection- SARS-CoV-2 (COVID-19) A&M Breathalyzer (PROTECT Kiosk) for Operational Medicine
NCT06402318 ·Status: RECRUITING